Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

$15 Million VC Fund to Back Israel-Tianjin Transfer Projects

publication date: Dec 24, 2010
The Tianjin-Israel Biomedical Equity Investment Fund raised 100 million RMB ($15 million) with a goal of sponsoring the transfer of Israeli biomedical projects to Tianjin. The fund is co-managed by Tianjin Venture Capital Management Co., Ltd. and Israel Infinity Group. It will invest in biomedical ventures, which will also include medical equipment, health care and innovation in medical models.  More details....


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital